Loading clinical trials...

Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL) | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT02273856

Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)

The purpose of this study is to document the pharmacological treatment strategies used in treatment naïve and previously treated relapsed/refractory iNHL/CLL patients in the Middle East and North Afri...

Lead sponsor: Astellas Pharma International B.V.•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not Recruiting

Retention Rate of Acalabrutinib in a Non-interventional Setting

NCT05645172 · Chronic Lymphocytic Leukaemia (CLL)

COMPLETEDPhase 1

AZD6738 First Time in Patient Multiple Ascending Dose Study

NCT01955668 · 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),, Prolymphocytic Leukaemia (PLL), and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 21, 2016Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment25

Start dateJan 2015

Last updatedJun 21, 2016

Condition

Indolent Non Hodgkin's Lymphoma (iNHL)Chronic Lymphocytic Leukaemia (CLL)

Locations shown

Site JO96201 King Abdullah University Hospital

Irbid, Irbid Governorate

Site KW96501 Kuwait Cancer Control Center

Ash Shuwaykh, Shuwaikh

Site Hammoud Hospital University Medical Center

Beirut, Beyrouth

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions